| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Product containing human tick borne encephalitis immunoglobulin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Human tick borne encephalitis immunoglobulin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Human tick-borne encephalitis immunoglobulin injection solution 1 mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human tick borne encephalitis immunoglobulin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Human tick-borne encephalitis immunoglobulin injection solution 2 mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human tick borne encephalitis immunoglobulin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Human tick-borne encephalitis immunoglobulin injection solution 5 mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human tick borne encephalitis immunoglobulin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Human tick-borne encephalitis immunoglobulin injection solution 10 mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human tick borne encephalitis immunoglobulin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Human tick-borne encephalitis immunoglobulin injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human tick borne encephalitis immunoglobulin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing human tick borne encephalitis immunoglobulin in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Human tick borne encephalitis immunoglobulin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only human tick borne encephalitis immunoglobulin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Human tick borne encephalitis immunoglobulin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Human tick borne encephalitis immunoglobulin only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Human tick borne encephalitis immunoglobulin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.4-SNAPSHOT
|
FHIR Version n/a
User: [n/a]